13 studies found for:    Open Studies | "Dysentery"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
Conditions: Acute Watery Diarrhea;   Dysentery/Febrile Diarrhea
Interventions: Drug: Single dose rifaximin 1650 mg;   Drug: Single dose azithromycin 500 mg;   Drug: Single dose levofloxacin 500 mg;   Drug: Single dose azithromycin 1000 mg plus loperamide;   Drug: Single dose azithromycin 1000 mg plus placebo
2 Not yet recruiting Auranofin Trial for GI Protozoa
Conditions: Giardiasis;   Amoebic Dysentery
Interventions: Drug: Auranofin;   Other: Placebo
3 Not yet recruiting SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Interventions: Biological: SF2a-TT15 vaccine;   Biological: SF2a-TT15 vaccine + adjuvant;   Biological: Placebo;   Biological: Placebo + adjuvant
4 Recruiting Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Intervention: Biological: Shigella flexneri 2a InvaplexAR
5 Unknown  Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections
Condition: Dysentery
Intervention: Other: Laboratory Tests
6 Unknown  Auranofin PK Following Oral Dose Administration
Condition: Amoebiasis
Intervention: Drug: Auranofin
7 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
8 Not yet recruiting Shigella Sonnei 53G Challenge
Condition: Healthy
Intervention: Biological: Shigella sonnei 53G
9 Not yet recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
10 Recruiting Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Condition: Shigellosis
Interventions: Biological: Flexyn2a;   Biological: Placebo
11 Recruiting Etiological Diagnosis of Traveler's Diarrhoea
Condition: Traveler's Diarrhoea
Intervention: Other: Rectal swab
12 Not yet recruiting Clinical Trial of CBS-2004 (Bimuno)® in Prevention of Travelers' Diarrhea
Condition: Traveler's Diarrhea
Interventions: Drug: Bimuno® (galacto-oligosaccharides);   Drug: Placebo
13 Recruiting Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Conditions: Travelers' Diarrhea;   Functional Bowel Disorders;   Reactive Arthritis
Interventions: Drug: Rifaximin;   Drug: Placebo

Indicates status has not been verified in more than two years